Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases

Gut

Volumn 35, Issue 2, 1994, Pages 231-235

  Cellier, C ^a   Sahmoud, T ^b   Froguel, E ^h   Adenis, A ^c   Belaiche, J ^d   Bretagne, J F ^e   Florent, C ^f   Bouvry, M ^g   Mary, J Y ^h   Modigliani, R ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d CHU SART TILMAN   (Belgium)

^e PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^f HÔPITAL SAINT ANTOINE   (France)

^g CENTRE HOSPITALIER RENÉ DUBOS   (France)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; ENDOSCOPY; FEMALE; FRANCE; HUMAN; ILEUM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARAMETER; PRIORITY JOURNAL;

EID: 0028267886     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.35.2.231     Document Type: Article

References (26)

1. Modigliani R, Mary JY, GETAID. Reproducibility of colonic findings in Crohn's disease: a prospective multicenter study of interobserver variation. Dig Dis Sci 1987; 32: 1370-9.
2. Mary JY, Modigliani R, GETAID. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Gut 1989; 30: 983-9.
3. Modigliani R, Mary JY, Simon JF, et al. Clinical biological and endoscopie picture of attacks of Crohn's disease; evolution on prednisolone. Gastroenterology 1990; 98: 811-18.
4. Bernades P, Hecketsweiler P, Benozio M, Descos L, Geffroy Y, Hemet J, et al. Proposition d'un système de critères pour le diagnostic des entèrocolites inflammatoires (maladie de Crohn et rectocolite hémorragique). Une étude coopérative du GREC. Gastroentérol Clin Biol, 1978; 2: 1047-54.
5. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979; 77: 843-6.
6. Morrison DF. Multivariate statistical methods. 2nd ed. New York: McGraw Hill, 1976: 102-5.
7. Kendall MG, Stuart A. The advanced theory of statistics. 3rd ed, vol 1. New York: Hafner, 1973: 85-6.
8. Siegel S. Non parametric statistics for the behavioral series. New York: McGraw Hill, 1956: 116-26/202-15.
9. Draper NR, Smith H. Applied regression analysis. New York: John Willey & Sons. 1966: 117/171-2.
10. Beck IT. Laboratory assessment of inflammatory bowel disease. Dig Dis Sci 1987; 32 (suppl): 26-41.
11. Gomes P, Du Boulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986; 27: 92-5.
12. Saverymuttu SH, Peters AM, Lavender JP, Pepys MB, Hodgson HJF, Chadwick VS. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of Crohn's disease. Gastroenterology 1983; 85: 1333-9.
13. Prantera C, Luzi C, Olivotto P, Levenstein S, Cerro P, Fanucci A. Relationship between clinical and laboratory parameters and length of lesion in Crohn's disease of small bowel. Dig Dis Sci 1984, 29: 1093-7.
14. Bucknell NA, Williams GT, Barham CI, Lennard-Jones JE. Depth of ulceration in acute colitis. Correlation with outcome and clinical and radiologic features. Gastroenterology 1980; 79: 19-25.
15. Andre C, Descos L, Landais P, Fermanian J. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index. Gut 1981; 22: 571-4.
16. Van Hees AM, Van Elteren PH, Van Lier HJJ, Van Tongeren JHM. An index of inflammatory activity in patient with Crohn's disease. Gut 1980; 21: 279-86.
17. Fagan EA, Dyck RF, Maton PN, et al. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1982; 12: 351-9.
18. Meyers S, Wolke A, Field SP, Feuer EJ, Johnson JW, Janowitz HD. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology 1985; 89: 13-8.
19. Sachar DB, Smith H, Chan S, Cohen LB, Lichtiger S, Messer J. Erythrocyte sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J Clin Gastroenterol 1986; 8: 647-50.
20. Florent C, L'Hirondel C, Desmasures C, Giraudeaux V, Bernier JJ. Evaluation de l'évolutivité de la maladie de Crohn et de la rectolite hémorragique par la mesure de la clairance fécale de l'alpha1 antitrypsine. Gastroenterol Clin Biol 1981; 5: 193-7.
21. Fischbach W, Becker W, Mössner J, Koch W, Reiners C. Faecal alpha1 antitrypsin and excretion of 111 Indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases. Gut 1987; 28: 386-93.
22. Karbach U, Ewe K, Bodenstein H. Alpha1 antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease. Gut 1983; 24: 718-23.
23. Karbach U, Ewe K, Dehos H. Antiinflammatory treatment and intestinal alphal-antitrypsin clearance in active Crohn's disease. Dig Dis Sci 1985; 30: 229-35.
24. Mueller Ch, Knoflach P, Zielinski C. T-cell activation in Crohn's disease: Increased levels of soluble interleukin-2 receptors in serum and in supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 1990; 98: 639-46.
25. Landi B, Nguyen Anh T, Cortot A, Soule JC, Rene E, Gendre JP, et al., and the Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. Gastroenterology 1992; 102: 1647-53.
26. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 98; 956-63.